GlassScriptPhysician profile
Alexandra Mcmurray
NPI 1942246749
$537.44
in general payments reported to CMS, 2019-2025
8 companies · $63.96 in 2025
The $63.96 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $37.45 · 2021: $63.62 · 2023: $57.60 · 2024: $70.66 · 2025: $63.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.25 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $160.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $50.00 | 2019 | |
| Neuronetics, INC. | $30.80 | 2019-2020 | |
| Livanova USA, INC. | $21.59 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Bausch Health US, LLC | $14.04 | 2019 | |
| Neurocrine Biosciences, INC. | $13.58 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Mcmurray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.